Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
314.8 USD | +0.76% | +1.80% | +9.02% |
01:58pm | HSBC Adjusts Price Target on Amgen to $356 From $322 | MT |
12:53pm | Amgen and AstraZeneca's Lung Disease Drug Study Reports Mixed Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.02% | 168B | |
+32.95% | 693B | |
+29.39% | 584B | |
-3.19% | 372B | |
+20.10% | 332B | |
+6.66% | 294B | |
+14.06% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
-0.50% | 162B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Amgen Q1 Non-GAAP Earnings Decline, Revenue Increases; Adjusts Full-Year Guidance; Shares Advance Premarket